Clinical Trial Update: Prevalence of Subclinical Atherosclerosis and Its Associated Factors in Hyperlipidemic Korean Adults With Diabetes

View source ↗

Summary

This clinical trial update reports on the prevalence of subclinical atherosclerosis and its associated factors in hyperlipidemic Korean adults with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Dyslipidemia

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Dyslipidemia | Status: COMPLETED